Stent
A stent is disclosed that has an elongated body composed of a bioabsorbable polymer having a proximal end, a distal end, two open spiral channels formed on the exterior surface of the body to provide fluid communication between the proximal end and the distal end. The stent also has a central lumen open at the proximal and distal ends of the stent for the passage of a guide wire. A method for using the stent and a kit containing the stent are also disclosed.
1. A method of making a stent, comprising:
forming an elongated body comprising a biodegradable material, wherein the elongated body has a proximal end, a distal end and a central lumen open at the proximal and distal ends of the stent for the passage of a guide wire; and
twisting the elongated body to form at least one open spiral channels on the exterior surface of said body to provide fluid communication between said proximal end and said distal end; and
shaping the stent's geometry by optimizing fluid flow rate between said proximal end and said distal end, and optimizing flexibility of the stent, by adjusting a rotation rate of the spiral channels along the stent based on the optimized fluid flow rate, and
wherein the central lumen is not in fluid communication with the open spiral channels, and wherein said at least one open spiral channel has a rotation rate of at least 1 twist per inch.
2. The method of claim 1 , wherein the elongated body is formed by extrusion.
3. The method of claim 1 , wherein said at least one open spiral channel has a rotation rate of between about 1.5 and 3.5 twists per inch.
4. The method of claim 1 , wherein said at least one open spiral channel has a rotation rate of at least about 2 twists per inch.
5. The method of claim 1 , wherein said channels are on opposite sides on the exterior surface of said body.
6. The method of claim 1 , further comprising forming an anti-migration device on the elongated body.
7. The method of claim 1 , wherein said elongated body further comprises a biological agent.
8. The method of claim 7 , wherein said biological agent is selected from the group consisting of chemotherapeutic agents, antimicrobial agents and gene transfer agents.
9. The method of claim 1 , wherein said stent has a pre-implantation diameter D pre and is in situ expandable upon absorption of a body fluid to a post-implantation diameter D post , wherein D post is greater than D pre .
10. The method of claim 1 , wherein the elongate body further comprises a radio-opaque substance.
11. The method of claim 1 , wherein the biodegradable material comprises bioabsorbable polymer.
12. The method of claim 11 , wherein the biodegradable polymer comprises PEG and p-dioxanone.
13. The method of claim 11 , wherein the bioabsorbable polymer comprises PPDO.
14. The method of claim 11 , wherein the bioabsorbable polymer comprises PLA, trimethylene carbonate and caprolactone.
15. The method of claim 1 , further comprising:
recording a target lumen's shape by optical photography and/or optical videography; and
shaping the stent's geometry of corresponding zones and connector regions of the stent to the target lumen in accordance with the recorded target lumen's shape.